- Home
- WF vs NBIX Comparison
WF vs NBIX Comparison
Compare WF & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- NBIX
- Stock Information
- Founded
- WF 1899
- NBIX 1992
- Country
- WF South Korea
- NBIX United States
- Employees
- WF N/A
- NBIX N/A
- Industry
- WF Commercial Banks
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WF Finance
- NBIX Health Care
- Exchange
- WF Nasdaq
- NBIX Nasdaq
- Market Cap
- WF 13.5B
- NBIX 14.4B
- IPO Year
- WF N/A
- NBIX 1996
- Fundamental
- Price
- WF $53.77
- NBIX $150.87
- Analyst Decision
- WF
- NBIX Strong Buy
- Analyst Count
- WF 0
- NBIX 18
- Target Price
- WF N/A
- NBIX $172.06
- AVG Volume (30 Days)
- WF 50.5K
- NBIX 1.0M
- Earning Date
- WF 10-29-2025
- NBIX 10-28-2025
- Dividend Yield
- WF 3.96%
- NBIX N/A
- EPS Growth
- WF 22.80
- NBIX 12.44
- EPS
- WF 3.03
- NBIX 4.19
- Revenue
- WF $7,217,708,955.00
- NBIX $2,682,700,000.00
- Revenue This Year
- WF N/A
- NBIX $23.68
- Revenue Next Year
- WF $4.13
- NBIX $18.02
- P/E Ratio
- WF $5.81
- NBIX $35.78
- Revenue Growth
- WF 2.02
- NBIX 19.61
- 52 Week Low
- WF $29.44
- NBIX $84.23
- 52 Week High
- WF $57.97
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- WF 45.12
- NBIX 59.16
- Support Level
- WF $54.26
- NBIX $133.62
- Resistance Level
- WF $55.97
- NBIX $157.67
- Average True Range (ATR)
- WF 0.96
- NBIX 4.58
- MACD
- WF 0.09
- NBIX 0.98
- Stochastic Oscillator
- WF 25.51
- NBIX 67.98
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.